healthcare
Queen's Park Equity backs Blue Ribbon MBO
The deal is the sixth from QPE's Equity Fund I
Limerston exits Prism to Charme
Charme will complete the deal through Charme IV, which has raised EUR 700m to date
AlbionVC hires Gilmartin from McKinsey
Molly Gilmartin is a founder of AlbionVC portfolio company Pando, a developer of a messaging tool for doctors
UCB, Ysios lead EUR 50m Series A for SpliceBio
Round for the gene therapy specialist is the largest ever Series A for a Spanish biotechnology company
Pictet holds first close for healthcare fund-of-funds
Around 40% of the target USD 400m will be allocated to co- and direct investments
Gilde Healthcare buys Europin
The GP will merge it with portfolio company Acti-Med
Lauxera closes first health tech fund on EUR 260m
Debut fund will invest EUR 20m-40m in European and US health technology companies
Five Arrows Growth Capital leads EUR 80m fundraise for Padoa
Kamet Ventures will retain a majority stake in the startup
Silverfleet reaps 2.6x in Care Fertility sale to Nordic Capital
Nordic Capital buys the IVF clinics chain for GBP 300m, equating to 15.7x EBITDA
Keensight Capital to buy Symeres from Gilde Healthcare
Gilde's exit comes four years after it invested in the drug discovery and medicinal chemistry company
Softbank leads $225m series-D round for Exscientia
Japanese investor provided additional $300m equity commitment that can be drawn at the company's discretion
CPPIB, Fidelity lead €262m series-D round for Kry
Company was founded six years ago and has so far raised nearly €500m over five rounds
MTIP holds first close for second fund
Digital-health-focused growth investor has a hard-cap of €250m and target of €200m for MTIP Fund II
KKR invests $100m in Nordic Bioscience
GP is investing from Health Care Strategic Growth Fund, which held a final close in November 2017 on $1.2bn
Biotech market provides dose of optimism
In the past year, the biotech market has seen buoyant activity, reaching record levels of investments
Monterro buys e-health software provider Bliksund
Company is looking to expand in Sweden, Denmark and the UK first, but also further abroad
CVC acquires System C – report
William Blair advised on the sale process, which was marketed based on £80m sales and £15m EBITDA
Braavos leads SpyBiotech's $32.5m series-A
Proceeds will advance the clinical development of SpyBiotech's vaccine technology platform
Soleus leads $35m series-C extension for Inivata
Investment will primarily be used to accelerate the clinical development and rollout of RaDaR
Register for the Healthcare Sector Focus virtual event
Our expert speakers will discuss the short-term impacts of Covid-19, as well as the longer-term effect on traditional healthcare infrastructure
Octopus to launch £100m healthcare-focused fund
In conjunction with the announcement, the firm has hired an investment team from TenX Health
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline
Heal Capital closes debut fund on €100m
Healthtech-focused VC sees opportunities in the developing European market, managing director Christian Weiß tells Unquote